Managing the Condition Through Diet
At a Glance
Tyrosinemia Type 2 is managed mainly with a carefully prescribed low-protein diet and medical formula that limit tyrosine and phenylalanine while supporting growth. Regular blood tests and a written sick-day plan help caregivers keep treatment safe during illness.
Managing Tyrosinemia Type 2 relies almost entirely on a highly specialized diet. Because your child’s body cannot break down the amino acid tyrosine, the goal of treatment is to limit how much of it enters their system while still providing all the nutrients they need to grow and thrive.
The Gold Standard: Dietary Protein Restriction
The most effective way to lower tyrosine levels is to strictly limit the intake of natural protein [1]. Protein is made up of amino acids, including tyrosine and phenylalanine (which the body can convert into tyrosine). By restricting these, you directly reduce the “fuel” that causes tyrosine to build up [2].
- Low-Protein Foods: Your child’s diet will focus on foods naturally low in protein, such as many fruits, vegetables, and specialized low-protein grains [3].
- High-Protein Avoidance: Foods like meat, fish, eggs, dairy, beans, and nuts are typically eliminated or very strictly limited by the dietitian’s specific prescription, because even small amounts can cause tyrosine levels to spike [3]. It is critical that you never independently eliminate all protein without a medical prescription, as this creates a severe risk of inadequate calories, essential amino acids, and stunted growth.
The Role of a Metabolic Dietitian
You are not expected to calculate these complex nutritional needs alone. A metabolic dietitian is a vital member of your care team. They will provide an individualized “prescription” for the number of grams of natural protein, phenylalanine, and tyrosine your child can have each day based on their age, weight, and blood test results [4].
Specialized Medical Formula
Since your child cannot eat standard high-protein foods, they must get their essential protein substitute from a medical formula (sometimes called medical milk) [4].
This formula is specially engineered to contain the amino acids, vitamins, and minerals your child needs for healthy brain and body development—except for tyrosine and phenylalanine [2]. This is designed to support growth, which must be monitored by your care team [4]. Consistent use of this formula is the foundation of long-term health in Tyrosinemia Type 2.
Expected Results of Treatment
One of the most encouraging aspects of dietary treatment is how quickly physical symptoms can improve.
- Rapid Relief: In many cases, painful eye symptoms and skin thickening begin to resolve shortly after starting the diet [3].
- Healing Time: Research has shown that corneal defects and eye pain can resolve in as little as one month once tyrosine levels are brought under control [5].
- Long-Term Protection: While skin and eye issues heal quickly, the main reason for staying strictly on the diet long-term is to reduce the risk of developmental delays or intellectual disability [1][6].
A Critical Warning: Nitisinone
It is very important to understand that nitisinone (brand name Orfadin), which is the standard treatment for Tyrosinemia Type 1, is not the standard treatment for Tyrosinemia Type 2 [7].
Nitisinone works by blocking an enzyme “upstream” in the tyrosine breakdown pathway. While this is helpful in Type 1 because it prevents the formation of a deadly toxin called succinylacetone, it actually causes tyrosine levels in the blood to rise significantly [8]. In a child who already has Tyrosinemia Type 2, taking nitisinone could make their tyrosine levels high enough to trigger or worsen painful eye and skin symptoms [7][9]. Do not start, stop, or change nitisinone without the direct instruction of your metabolic specialist, particularly because stopping it abruptly could be extremely dangerous if the diagnosis is actually Type 1.
Monitoring Success and Planning for “Sick Days”
Your care team will use frequent blood tests to monitor plasma tyrosine and phenylalanine levels [4]. These tests tell the dietitian if the protein restriction needs to be tightened or if your child needs more formula. By keeping these levels in range, you are giving your child the best chance for a healthy life.
A routine diet is not enough during acute illness. Fevers, vomiting, or a refusal to drink the medical formula can rapidly destabilize metabolic levels. You must ask your metabolic team for a written Sick-Day Emergency Plan that details whom to call, how to maintain calories if formula is refused, and at what point you must seek emergency care.
Common questions in this guide
What is the main dietary treatment for Tyrosinemia Type 2?
Why does my child need medical formula?
How quickly can eye and skin symptoms improve?
Is nitisinone recommended for Tyrosinemia Type 2?
What should I do if my child is sick and will not drink the formula?
How do we know whether the diet is working?
Get notified when new evidence is published on Tyrosinemia type 2.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (9)
- 1
Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation.
Peña-Quintana L, Scherer G, Curbelo-Estévez ML, et al.
Clinical genetics 2017; (92(3)):306-317 doi:10.1111/cge.13003.
PMID: 28255985 - 2
Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1).
Das AM
The application of clinical genetics 2017; (10()):43-48 doi:10.2147/TACG.S113310.
PMID: 28769581 - 3
Bilateral dendriform ulcer leading to an early diagnosis of tyrosinemia type 2.
Martin GC, de Lonlay P, Chapron T, et al.
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2020; (24(2)):120-122 doi:10.1016/j.jaapos.2019.12.007.
PMID: 32018000 - 4
[Screening for hereditary tyrosinemia and genotype analysis in newborns].
Tong F, Yang R, Liu C, et al.
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2019; (48(4)):459-464 doi:10.3785/j.issn.1008-9292.2019.08.18.
PMID: 31901053 - 5
A child with dendritiform eye lesions and developmental delay.
Gliagias V, Denisova K, Kang JJ
American journal of ophthalmology case reports 2022; (28()):101701 doi:10.1016/j.ajoc.2022.101701.
PMID: 36118278 - 6
Tyrosinemia type II: Novel mutations in TAT in a boy with unusual presentation.
Gokay S, Kendirci M, Ustkoyuncu PS, et al.
Pediatrics international : official journal of the Japan Pediatric Society 2016; (58(10)):1069-1072 doi:10.1111/ped.13062.
PMID: 27285949 - 7
Predicting tyrosinaemia: a mathematical model of 4-hydroxyphenylpyruvate dioxygenase inhibition by nitisinone in rats.
Ward JP, Dunster JL, Derks G, et al.
Mathematical medicine and biology : a journal of the IMA 2017; (34(3)):335-390 doi:10.1093/imammb/dqw006.
PMID: 27305933 - 8
Nitisinone-Induced Keratopathy in Alkaptonuria: A Challenging Diagnosis Despite Clinical Suspicion.
White A, C Tchan M
JIMD reports 2018; (40()):7-9 doi:10.1007/8904_2017_56.
PMID: 28879639 - 9
Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1.
van Ginkel WG, Rodenburg IL, Harding CO, et al.
Paediatric drugs 2019; (21(6)):413-426 doi:10.1007/s40272-019-00364-4.
PMID: 31667718
This page explains dietary management of Tyrosinemia Type 2 for informational purposes and does not constitute medical advice. Follow your metabolic specialist’s and dietitian’s individualized plan, especially during illness or before changing medicines.